Albert joined Vivo Capital in 2017 and is a member of the investment team.
Albert has more than 23 years of experience in institutional asset management. His early experience canvassed the sectors of Technology, Energy, Retail, Financials and MedTech/Pharma. Throughout his career, he has focused on trading technology, market sentiment, cost-effectiveness and compliance.
For the past 15 years, Albert has focused more specifically on the SMID Cap biotech and pharma space. In this role, Albert manages and executes all trading activity, including trading scenario analysis, order creation and management, execution of orders and management of the firm’s trading relationships. Prior to Vivo, Albert was the Head Trader at Palo Alto Investors.
Albert holds a B.A. from Harvard with a concentration in Biology.